Truvada and Descovy are contraindicated for use as<unk>  (PrEP) in individuals who have an unknown or positive HIV status. HIV positive or negative status must be determined before someone begins the use of either of these medications as PrEP. Additionally, any hypersensitivity or severe allergy to any ingredient, emtricitabine, tenofovir disoproxil, or tenofovir alafenamide is a contraindication for continued use of these medications.
Pre-exposure prophylaxis
Post-exposure prophylaxis
Transmission-based precautions
Protective isolation
Vaccine storage
Vaccine therapy
Pulse vaccination strategy
Vaccine bundling